Best Pharmaceuticals for Children Act Data Coordination Center

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH NICHD

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N94026R00008

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN12

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
Documents1
The National Institutes of Health (NIH), through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), has issued a solicitation seeking proposals for the establishment and operation of the Best Pharmaceuticals for Children Act (BPCA) Data Coordination Center (DCC). This procurement aims to secure a comprehensive data coordination resource to support the clinical research activities conducted under the BPCA program, which is dedicated to improving pediatric drug research and ensuring the safe and effective use of pharmaceuticals in children. The scope of this requirement encompasses a broad range of scientific and technical support services essential for the successful execution of BPCA clinical studies. Key responsibilities include project management, data management, statistical analysis, clinical study monitoring, regulatory and safety oversight, and other related activities necessary to facilitate and coordinate BPCA research efforts. The selected contractor will be expected to provide robust infrastructure and expertise to manage complex clinical data, ensure regulatory compliance, and support the scientific integrity of BPCA studies. The Government anticipates awarding a single-award, cost-reimbursement, Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract. The contract will feature a potential ordering period of up to ten years, with specific requirements and deliverables to be defined through individual task orders issued over the contract’s lifecycle. This structure allows for flexibility in addressing evolving program needs while maintaining continuity and high standards of data coordination and support. This opportunity is classified under NAICS code 541715, “Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology),” reflecting the technical and scientific nature of the work. The Product Service Code (PSC) is AN12. The place of performance is within the United States. The contracting entity is the National Institutes of Health NICHD, a federal office within the Department of Health and Human Services. The primary point of contact for this solicitation is Theresa Ranjit ([email protected]), with Alice Pagan serving as the Contracting Officer ([email protected]). Interested offerors should note the following key dates: questions regarding the solicitation are due by November 20, 2026, and complete proposals must be submitted by December 18, 2026, at 4:00 p.m. Eastern Standard Time. The full solicitation, including the Statement of Work, proposal preparation instructions, evaluation criteria, and all applicable terms and conditions, is available in the attached Request for Proposals (RFP) on the official SAM.gov opportunity page. This procurement represents a significant opportunity for organizations with demonstrated capabilities in clinical research data coordination, project management, and regulatory support within the pediatric pharmaceutical research domain. Contractors considering this opportunity should carefully review the solicitation and attachments to ensure alignment with their expertise and operational capacity, as the requirements and expectations will remain consistent throughout the contract period. For further details and to access the solicitation documents, interested parties should refer to the official notice at https://sam.gov/opp/7a9a273a5e614865aa0867cfef3c58a1/view.